| 2024-06-04 | Sale | Catalyst Pharmaceuticals, Inc. CPRX | President and CEO | 17,323 0.0146% | $15.97 | $276,735 | -3.87% | |
| 2017-05-17 | Palisade Bio, Inc. PALI | Chief Executive Officer | 7,500 0.0105% | $4.00 | $30,000 | -61.85% | ||
| 2017-02-24 | Palisade Bio, Inc. PALI | Chief Executive Officer | 2,591 0.0039% | $3.86 | $10,001 | -58.55% | ||
| 2017-01-25 | Palisade Bio, Inc. PALI | Chief Executive Officer | 2,841 0.0043% | $3.52 | $10,000 | -46.88% | ||
| 2016-12-23 | Palisade Bio, Inc. PALI | Chief Executive Officer | 32,259 0.0037% | $0.31 | $10,000 | -53.36% | ||
| 2016-11-25 | Palisade Bio, Inc. PALI | Chief Executive Officer | 35,715 0.0041% | $0.28 | $10,000 | -55.6% | ||
| 2016-10-25 | Palisade Bio, Inc. PALI | Chief Executive Officer | 35,715 0.0041% | $0.28 | $10,000 | -13.47% | ||
| 2016-09-23 | Palisade Bio, Inc. PALI | Chief Executive Officer | 31,250 0.0045% | $0.32 | $10,000 | -11.91% |